FLT3 as a Therapeutic Target in Childhood Acute Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|6|703-714

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.6, 2007-06, pp. : 703-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3449-3457

Bentham Science Publishers

Access to resources Recommend Favorite

The Cytoskeleton as a Therapeutic Target in Childhood Acute Leukemia:Obstacles and Opportunities

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 739-749

Bentham Science Publishers

Access to resources Recommend Favorite

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia

By Qu Shuang   Liu Bin   Guo Xiaoling   Shi Hongshun   Zhou Meifeng   Li Li   Yang Shulan   Tong Xiuzhen   Wang Haihe  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2130-2141

Blackwell Publishing

Access to resources Recommend Favorite

Bench to Bedside Targeting of FLT3 in Acute Leukemia

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 781-789

Bentham Science Publishers

Access to resources Recommend Favorite

Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1867-1883

Bentham Science Publishers

Access to resources Recommend Favorite